Crosstalk between cyclophilins and T lymphocytes in coronary artery disease

High Serum Cyclophilin C levels as a risk factor marker for Coronary Artery Disease

(2019) Amparo Alfonso et al.   Scientific Reports

Cyclophilins: Less Studied Proteins with Critical Roles in Pathogenesis

(2018) Khushwant Singh et al.   PHYTOPATHOLOGY

Cyclophilin D deficiency protects against the development of mitochondrial ROS and cellular inflammation in aorta

(2018) Xiaojing Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Preface: Pathology and Pharmacology of Atherosclerosis

(2017) Amanda C. Foks et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Future of the Prevention and Treatment of Coronary Artery Disease

(2016) Philippe Gabriel Steg et al.   CIRCULATION JOURNAL

Spongionella Secondary Metabolites, Promising Modulators of Immune Response through CD147 Receptor Modulation

(2016) Jon Andoni Sánchez et al.   Frontiers in Immunology

Extracellular cyclophilins in health and disease

(2015) Michael Bukrinsky   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases

(2015) Gianluca Lorenzo Perrucci et al.   CARDIOVASCULAR RESEARCH

The role of EMMPRIN in T cell biology and immunological diseases

(2015) Jennifer Nancy Hahn et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The mitochondrial permeability transition: A current perspective on its identity and role in ischaemia/reperfusion injury

(2015) Andrew P. Halestrap et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Cyclosporine before PCI in Patients with Acute Myocardial Infarction

(2015) Thien-Tri Cung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases

(2014) Peter Seizer et al.   CARDIOVASCULAR RESEARCH

Anti-inflammatory therapies for cardiovascular disease

(2014) P. M. Ridker et al.   EUROPEAN HEART JOURNAL

Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes

(2012) Surya Ramachandran et al.   PROTEOMICS

Disrupting the EMMPRIN (CD147)–Cyclophilin A Interaction Reduces Infarct Size and Preserves Systolic Function After Myocardial Ischemia and Reperfusion

(2011) Peter Seizer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cyclosporin A Associated Helicase-Like Protein Facilitates the Association of Hepatitis C Virus RNA Polymerase with Its Cellular Cyclophilin B

(2011) Kengo Morohashi et al.   PLoS One

Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics

(2010) V. Yurchenko et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II–induced aortic aneurysms

(2009) Kimio Satoh et al.   NATURE MEDICINE

Targeting the chemotactic function of CD147 reduces collagen-induced arthritis

(2008) Jesse M. Damsker et al.   IMMUNOLOGY

Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor κB–Dependent Inflammation in Monocytes

(2007) Roland Schmidt et al.   CIRCULATION RESEARCH